MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock (STOK)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Stoke Therapeutics, Inc. Common Stock
Symbol
STOK
Shares outstanding
52.7M shares
Disclosed Ownership
3.43M shares
Ownership
6.5%
Form type
SCHEDULE 13G/A
Filing time
03 Feb 2025, 16:36:44 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 6.5% 3.43M 0 3.43M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 5.4% 2.88M 0 2.88M Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC